Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection

Immunology and Cell Biology

Volumn 91, Issue 10, 2013, Pages 642-651

  Kaur, Gurpreet ^a   Sts, Chitradevi ^a   Nimker, Charu ^a   Singh, Mrinalini ^a   Saraswat, Deepika ^a   Saxena, Shweta ^a   Bansal, Anju ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

DNA vaccines; fusion DNA vaccine; GroEL; IL 22; immunity

Indexed keywords

CHAPERONIN 60; GAMMA INTERFERON ANTIBODY; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL LOAD; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DNA PURIFICATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; ISOLATION AND PURIFICATION; LETHAL DOSE; LIVER; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECOMBINANT PLASMID; SALMONELLA TYPHI; SALMONELLOSIS; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WESTERN BLOTTING; X RAY FILM;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA TYPHI;

ANIMALS; ANTIBODY FORMATION; BACTERIAL LOAD; CELL PROLIFERATION; CHAPERONIN 60; CYTOKINES; DNA, RECOMBINANT; FEMALE; GENE EXPRESSION; GENETIC VECTORS; IMMUNITY; IMMUNOGLOBULIN G; INTERLEUKINS; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PROTEIN BIOSYNTHESIS; SALMONELLA INFECTIONS, ANIMAL; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; VACCINES, DNA;

EID: 84888390075     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.61     Document Type: Article

References (78)

1. Ritossa F. A new puffing pattern induced by temperature shock and dnp in drosophila. Experientia 1962; 18: 571-573
2. Smith DF, Whitesell L, Katsanis E. Molecular chaperones: biology and prospects for pharmacological intervention. Pharmacol Rev 1998; 50: 493-514
3. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185-194
4. Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-136
5. Zugel U, Kaufmann SHE. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12: 19-39
6. Kaufmann SHE, Schoel B. Heat shock proteins as antigens in immunity against infection and self. In: Morimoto RI, Tissieres A and Georgopoulos C (eds), The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor, Monograph Archive, New York, 1994, pp 495-531
7. Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine 1998; 16: 1391-1395
8. Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 2002; 26: 339-353
9. Hessel L, Debois H, Fletcher M, Dumas R. Experience with Salmonella Typhi Vi capsular polysaccharide vaccine. Eur J Clin Microbiol Infect Dis 1999; 18: 609-620
10. Coutanceau E, Legras P, Marsollier L, Reysset G, Cole ST, Demangel C. Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against buruli ulcer. Microbes and Infect 2006; 8: 2075-2081
11. Noll A, Bucheler N, Bohn E, Schirmbeck R, Reimann J, Autenrieth IB. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur J Immunol 1999; 29: 986-996
12. Ribeiro AM, Bocca AL, Amaral AC, Faccioli LH, Galetti FCS, Zarate-Blades CR et al. DNA-hsp65 vaccination induces protection in mice against paracoccidioides brasiliensis infection. Vaccine 2009; 27: 606-613
13. Santos-Junior RR, Sartori A, De Franco M, Filho OG, Coelho-Castelo AA, Bonato VL et al. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum Gene Ther 2005; 16: 1338-1345
14. Davis HL. Plasmid DNA expression systems for the purpose of immunization. Curr Opin Biotechnol 1997; 8: 635-646
15. Egan MA, Israel ZR. The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines. Clin Appl Immunol Rev 2002; 2: 255-287
16. Garmory HS, Brown KA, Titball RW. DNA vaccines: improving expression of antigens. Genet Vaccines Ther 2003; 1: 2
17. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993; 90: 4523-4527
18. Irvine KR, Rao JB, Rosenberg SA, Restifo NP. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 1996; 156: 238-245
19. Li Q, Zhu Y, Chu J, Wang Y, Xu Y, Hou Q et al. Protective immunity against Bordetella pertussis by a recombinant DNA vaccine and the effect of coinjection with a granulocyte-macrophage colony stimulating factor gene. Microbiol Immunol 2006; 50: 929-936
20. Triccas JA, Sun L, Palendira U, Britton WJ. Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis. Immunol Cell Biol 2002; 80: 346-350
21. Xiang Z, Ertl HC. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995; 2: 129-135
22. Xin KQ, Hamajima K, Sasaki S, Honsho A, Tsuji T, Ishii N et al. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1. Immunology 1998; 94: 438-444
23. Hornef MW, Noll A, Schirmbeck R, Reimann J, Autenrieth IB. DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kda heat shock protein. Med Microbiol Immunol 2000; 189: 97-104
24. Maecker HT, Umetsu DT, DeKruyff RH, Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 1997; 15: 1687-1696
25. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164: 1814-1819
26. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282-289
27. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA et al. IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 2008; 14: 275-281
28. Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM et al. IL-22 induces an acute-phase response. J Immunol 2010; 185: 5531-5538
29. Ren X, Hu B, Colletti LM. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol 2010; 298: G74-G80
30. Schulz SM, Kohler G, Schutze N, Knauer J, Straubinger RK, Chackerian AA et al. Protective immunity to systemic infection with attenuated salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 2008; 181: 7891-7901
31. El-Shemi AG, Basalamah MA, Kensara OA, Ashshi AM. Interleukin-22 therapy attenuates the development of acute pancreatitis in rats. Clin Med Res 2011; 3: 82-88
32. Pan H, Hong F, Radaeva S, Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligandinduced injury via activation of Stat3. Cell Mol Immunol 2004; 1: 43-49
33. Bansal A, Paliwal PK, Sagi SS, Sairam M. Effect of adjuvants on immune response and protective immunity elicited by recombinant hsp60 (GroEL) of Salmonella typhi against S. Typhi infection. Mol Cell Biochem 2010; 337: 213-221
34. Paliwal PK, Bansal A, Sagi SS, Mustoori S, Govindaswamy I. Cloning, expression and characterization of heat shock protein 60 (GroEL) of Salmonella enterica serovar typhi and its role in protective immunity against lethal Salmonella infection in mice. Clin Immunol 2008; 126: 89-96
35. Paliwal PK, Bansal A, Sagi SS, Sairam M. Intraperitoneal immunization of recombinant hsp70 (Dnak) of Salmonella typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection. Vaccine 2011; 29: 6532-6539
36. Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F et al. DNA vaccines expressing B and T cell epitopes can protect mice from fmdv infection in the absence of specific humoral responses. Vaccine 2006; 24: 3889-3899
37. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996; 2: 893-898
38. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. DNA-mediated immunization to the hepatitis b surface antigen in mice: aspects of the humoral response mimic hepatitis b viral infection in humans. Proc Natl Acad Sci USA 1995; 92: 5307-5311
39. Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994; 91: 9866-9870
40. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994; 199: 132-140
41. Montgomery DL, Ulmer JB, Donnelly JJ, Liu MA. DNA vaccines. Pharmacol Ther 1997; 74: 195-205
42. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18: 927-974
43. Robinson HL. Nucleic acid vaccines: an overview. Vaccine 1997; 15: 785-787
44. Costa MP, McCulloch JA, Almeida SS, Dorella FA, Fonseca CT, Oliveira DM et al. Molecular characterization of the Corynebacterium pseudotuberculosis hsp60-hsp10 operon, and evaluation of the immune response and protective efficacy induced by hsp60 DNA vaccination in mice. BMC Res Notes 2011; 4: 243
45. Ulmer JB, Sadoff JC, Liu MA. DNA vaccines. Curr Opin Immunol 1996; 8: 531-536
46. Abdelnoor AM. Plasmid DNA vaccines. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 79-92
47. Scheerlinck J-PY. Genetic adjuvants for DNA vaccines. Vaccine 2001; 19: 2647-2656
48. Gonzalez-Smith A, Vemulapalli R, Andrews E, Onate A. Evaluation of Brucella abortus DNA vaccine by expression of cu-zn superoxide dismutase antigen fused to IL-2. Immunobiology 2006; 211: 65-74
49. Singha H, Mallick AI, Jana C, Isore DP, Goswami TK, Srivastava SK et al. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against brucella abortus. Microbes Infect 2008; 10: 1089-1096
50. Feng C, Jin J, Zou Q, Chen X, Zhou C, Wu B et al. Interleukin-21 inhibits humoral response to HIV DNA vaccine by enhancing Bcl-6 and Pax-5 expression. Viral Immunol 2012; 25: 131-140
51. Naderi M, Saeedi A, Moradi A, Kleshadi M, Zolfaghari MR, Gorji A et al. Interleukin-12 as a genetic adjuvant enhances hepatitis c virus NS3 DNA vaccine immunogenicity. Virol Sin 2013; 28: 167-173
52. Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998; 160: 1320-1329
53. Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS et al. Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. J Virol 2000; 74: 3427-3429
54. Zhao F, Wang S, Zhang X, Gu W, Yu J, Liu S et al. Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2. Can J Microbiol 2012; 58: 117-123
55. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12: 383-390
56. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol 2011; 23: 159-163
57. El-Shemi AG, Basalamah MA, Kensara OA, Ashshi AM. Interleukin-22 therapy attenuates the development of acute pancreatitis in rats. J Clin Med Res 2011; 3: 82-88
58. Torres CA, Yang K, Mustafa F, Robinson HL. DNA immunization: Effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 1999; 18: 805-814
59. Rothel JS, Waterkeyn JG, Strugnell RA, Wood PR, Seow HF, Vadolas J et al. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol Cell Biol 1997; 75: 41-46
60. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 2002; 20: S34-S39
61. DElios MM, Benagiano M, Della Bella C, Amedei A. T-cell response to bacterial agents. J Infect Dev Ctries 2011; 5: 640-645
62. Finkelman FD, Holmes J, Katona IM, Urban JF Jr., Beckmann MP, Park LS et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303-333
63. Spellberg B, Edwards JE Jr.. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32: 76-102
64. OGarra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000; 10: 542-550
65. Muhl H, Bachmann M, Pfeilschifter J. Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol 2011; 13: 340-348
66. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009; 42: 776-787
67. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE et al. Antimicrobial actions of the nadph phagocyte oxidase and inducible nitric oxide synthase in experimental Salmonellosis. I. Effects on microbial proliferation and host survival in vivo. J Exp Med 2000; 192: 237-248
68. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009; 5: 476-486
69. Ziesche E, Bachmann M, Kleinert H, Pfeilschifter J, Muhl H. The Interleukin-22/Stat3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 2007; 282: 16006-16015
70. Green SJ, Nacy CA, Meltzer MS. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to leishmania and other intracellular pathogens. J Leukoc Biol 1991; 50: 93-103
71. Edsall G, Gaines S, Landy M, Tigertt W, Sprinz H, Trapani R-J et al. Studies on infection and immunity in experimental typhoid fever I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa. J Exp med 1960; 112: 143-166
72. Spaun J. Studies on the influence of the route of immunization in the active mouse protection test with intraperitoneal challenge for potency assay of typhoid vaccines. Bull World Health Organ 1964; 31: 793
73. Esposito VM, Feeley JC, Leeder WD, Pittman M. Immunological response of three mouse strains to typhoid vaccine and vi antigen. J Bacteriol 1969; 99: 8-12
74. Collins FM, Carter PB. Growth of salmonellae in orally infected germfree mice. Infect Immun 1978; 21: 41-47
75. Godinez I, Haneda T, Raffatellu M, George MD, Paixao TA, Rolan HG et al. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype typhimurium in the intestinal mucosa. Infect Immun 2008; 76: 2008-2017
76. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14: 421-428
77. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA et al. Short protocols in molecular biology. John Wiley & Sons, New York, 2002
78. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008, Chapter 14: Unit 14.1.